Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma, Renal Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02122003
What this trial is testing

Second Line Sorafenib After Pazopanib in Patients With RCC

Who this might be right for
Metastatic Renal Cell Carcinoma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 16
Not applicableLooking for participantsNCT07680556
What this trial is testing

Promoting Response to IMmunotherapy by Exercise in Patients With Advanced Renal Cell Carcinoma

Who this might be right for
Oncology
Radboud University Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT00077129
What this trial is testing

Paclitaxel and Carboplatin in Treating Patients With Locally Advanced or Metastatic Renal Cell Cancer

Who this might be right for
Kidney Cancer
Eastern Cooperative Oncology Group 22
Testing effectiveness (Phase 2)UnknownNCT03827837
What this trial is testing

Famitinib Plus Anti-PD1 Therapy for Advanced Urinary System Tumor, Advanced Gynecological Tumors

Who this might be right for
Renal Cell CarcinomaUrothelial CarcinomaCervical Cancer+2 more
Jiangsu HengRui Medicine Co., Ltd. 265
Not applicableLooking for participantsNCT07018037
What this trial is testing

Role of TTV During First-line Immunotherapy Treatment in Patients With Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Regina Elena Cancer Institute 20
Testing effectiveness (Phase 2)UnknownNCT00293501
What this trial is testing

Tinzaparin in Treating Patients With Metastatic Kidney Cancer That Cannot Be Removed By Surgery

Who this might be right for
Kidney Cancer
University of Vermont 35
Testing effectiveness (Phase 2)Looking for participantsNCT07172386
What this trial is testing

Preoperative Therapy of Super-selective Tumor Artery Embolization Combined With Toripalimab and Axitinib in Advanced RCC

Who this might be right for
Renal Cell Carcinoma (RCC)
Tianjin Medical University Second Hospital 40
Early research (Phase 1)Study completedNCT00283075
What this trial is testing

Mouse Cancer Cell-containing Macrobeads in the Treatment of Human Cancer

Who this might be right for
Intraabdominal Cancers (Various Types)
The Rogosin Institute 56
Not applicableStudy completedNCT05729763
What this trial is testing

Three-dimensional Virtual Imaging to Improve the Accuracy of Standard CT-based Nephrometric Scores: a Prospective Multicentric Observational Study

Who this might be right for
Kidney NeoplasmsCarcinoma, Renal Cell
San Luigi Gonzaga Hospital 300
Not applicableStudy completedNCT04076787
What this trial is testing

Clinical Outcomes for Patients With Renal Cell Carcinoma Who Received First-Line Sunitinib

Who this might be right for
Metastatic Renal Cell Carcinoma
Pfizer 1,769
Testing effectiveness (Phase 2)Looking for participantsNCT07397611
What this trial is testing

Pre-NEOSHIFT-RCC: Neoadjuvant HIF-Inhibitor Immunotherapy in RCC

Who this might be right for
Renal Cell CarcinomaKidney CancerKidney Neoplasm+1 more
Dana-Farber Cancer Institute 32
Testing effectiveness (Phase 2)Study completedNCT02440334
What this trial is testing

Two and Three Dimensional Contrast-enhanced Ultrasound for Screening of Renal Cell Carcinoma Recurrence Following Cryoablation

Who this might be right for
Renal Cell Carcinoma
Thomas Jefferson University 53
Not applicableEnded earlyNCT01599832
What this trial is testing

Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Measuring Effects of Pazopanib Hydrochloride in Patients With Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CancerStage IV Renal Cell Cancer
University of Chicago 20
Not applicableStudy completedNCT03955393
What this trial is testing

FAZA PET IMAGING IN DETECTING LYMPH NODE METASTASES IN RENAL CELL CARCINOMA PATIENTS

Who this might be right for
Renal Cell Carcinoma (RCC)
IRCCS San Raffaele 20
Not applicableWithdrawnNCT02928263
What this trial is testing

Healthcare Cost and Resource Utilization Related to Metastatic Renal Cell Carcinoma Treatment With Intravenous and Oral Agents

Who this might be right for
Renal Cell Carcinoma
Bristol-Myers Squibb
Testing effectiveness (Phase 2)Ended earlyNCT03829501
What this trial is testing

A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced Malignancies

Who this might be right for
Squamous Cell Carcinoma of Head and NeckNon-small Cell Lung CancerHepatocellular Carcinoma+9 more
Kymab Limited 222
Testing effectiveness (Phase 2)Study completedNCT03012581
What this trial is testing

Secured Access to Nivolumab for Adult Patients With Selected Rare Cancer Types

Who this might be right for
Carcinoma, Renal CellHead and Neck NeoplasmSkin Neoplasms+3 more
UNICANCER 269
Not applicableNot Yet RecruitingNCT06032728
What this trial is testing

Multimodal Recurrence Scoring System for Stratifying Stage III Clear Cell Renal Cell Carcinoma of Receiving Adjuvant Treatment

Who this might be right for
Renal Cell Carcinoma
First Affiliated Hospital, Sun Yat-Sen University 488
Testing effectiveness (Phase 2)Ended earlyNCT03165721
What this trial is testing

A Phase II Trial of the DNA Methyl Transferase Inhibitor, Guadecitabine (SGI-110), in Children and Adults With Wild Type GIST,Pheochromocytoma and Paraganglioma Associated With Succinate Dehydrogenase Deficiency and HLRCC-associated Kidney Cancer

Who this might be right for
ParagangliomaGastrointestinal Stromal TumorsCarcinoma, Renal Cell+2 more
National Cancer Institute (NCI) 9
Not applicableStudy completedNCT00513175
What this trial is testing

Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia

Who this might be right for
Acute Myeloid LeukemiaMyelodysplasiaAcute Lymphoblastic Leukemia+8 more
University of California, San Francisco 44
Next Page